DMT1 and iron transport

Area of Science:

• Cellular Biology
• Biochemistry
• Molecular Medicine

Background:

• Divalent metal transporter 1 (DMT1), discovered in 1997, is a primary transporter of non-heme iron.
• DMT1 isoforms display cell-specific expression and subcellular localization, facilitating efficient iron uptake.
• Cellular iron uptake is tightly regulated by DMT1 expression via translational and degradation pathways to maintain homeostasis.

Purpose of the Study:

• To review the expression patterns of DMT1 across various cell and tissue types.
• To elucidate the function and transport mechanism of iron chaperones, focusing on PCBP2.
• To address the safe intracellular transport of ferrous iron, a potentially damaging species.

Main Methods:

• Literature review and synthesis of existing research on DMT1 and iron chaperones.
• Analysis of DMT1 expression data based on cell and tissue specificity.
• Examination of the proposed mechanisms for ferrous iron handling by chaperones.

Main Results:

• DMT1 plays a central role in cellular iron acquisition, with diverse expression profiles.
• Ferrous iron transport by DMT1 raises concerns due to potential reactive oxygen species production.
• Iron chaperones, such as PCBP2, are identified as key mediators for safe ferrous iron intracellular transport.

Conclusions:

• Understanding DMT1 expression is vital for comprehending iron metabolism in different physiological and pathological contexts.
• Iron chaperones like PCBP2 are essential for mitigating the risks associated with ferrous iron transport.
• Further research into DMT1 and iron chaperones will advance strategies for managing iron-related disorders.